Nu Wave Investment Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Nu Wave Investment Management, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 12, 2022	SELL	$595.12 - $698.43 $767,704 - $900,974	-1,290 Closed	0 $0
Q4 2021 Jan 18, 2022	BUY	$543.48 - $670.97 $39,130 - $48,309	72 Added 5.91%	1,290 $815,000
Q3 2021 Oct 18, 2021	BUY	$574.03 - $680.96 $699,168 - $829,409	1,218 New	1,218 $737,000
Q2 2021 Jul 16, 2021	SELL	$472.8 - $558.54 $350,817 - $414,436	-742 Closed	0 $0
Q1 2021 Apr 09, 2021	SELL	$446.73 - $548.2 $961,809 - $1.18 Million	-2,153 Reduced 74.37%	742 $351,000
Q4 2020 Jan 11, 2021	BUY	$478.3 - $607.98 $1.24 Million - $1.58 Million	2,601 Added 884.69%	2,895 $1.4 Million
Q3 2020 Oct 23, 2020	BUY	$544.75 - $658.21 $144,903 - $175,083	266 Added 950.0%	294 $164,000
Q2 2020 Jul 13, 2020	SELL	$493.32 - $643.92 $293,032 - $382,488	-594 Reduced 95.5%	28 $17,000
Q1 2020 Apr 14, 2020	BUY	$336.18 - $494.43 $201,035 - $295,669	598 Added 2491.67%	622 $304,000
Q4 2019 Jan 31, 2020	SELL	$274.13 - $376.51 $64,694 - $88,856	-236 Reduced 90.77%	24 $9,000
Q3 2019 Oct 15, 2019	BUY	$273.46 - $318.39 $49,222 - $57,310	180 Added 225.0%	260 $78,000
Q2 2019 Jul 18, 2019	SELL	$299.6 - $414.82 $354,127 - $490,317	-1,182 Reduced 93.66%	80 $25,000
Q1 2019 Apr 11, 2019	BUY	$372.08 - $439.57 $460,635 - $544,187	1,238 Added 5158.33%	1,262 $519,000
Q4 2018 Jan 22, 2019	BUY	$335.82 - $403.04 $7,388 - $8,866	22 Added 1100.0%	24 $9,000
Q3 2018 Oct 23, 2018	SELL	$351.14 - $408.51 $351 - $408	-1 Reduced 33.33%	2 $1,000
Q2 2018 Aug 01, 2018	BUY	$284.6 - $344.99 $853 - $1,034	3 New	3 $1,000

1,484

83.7M

1.22M

1.5M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Nu Wave Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nu Wave Investment Management, LLC with notifications on news.